comparemela.com

Latest Breaking News On - Consortium for long read sequencing colo - Page 1 : comparemela.com

PacBio Announces Third Quarter 2022 Financial Results

/PRNewswire/ PacBio (NASDAQ: PACB) today announced financial results for the quarter ended September 30, 2022. Third quarter results Revenue of $32.3.

New yorkUnited statesChristian henryLizelda lopezTodd friedmanPacific biosciencesExchange commissionBroad instituteConsortium for long read sequencing coloResearch useSecurities exchangeCalifornia incTwist bioscienceScientific advisory boardLong read sequencingChief executive

Global initiative aims to identify disease-linked genome variations

A newly formed international collaborative science project created with the aim of identifying variations in the human genome linked with disease is cal.

United statesEdd leeMichael schatzConsortium for long read sequencing coloBloomberg distinguished professor at johns hopkins universityNational human genome research instituteLong read sequencingHuman genomics segment marketingInformatics lab spaceHealth officeData science strategyBloomberg distinguished professorJohns hopkins university

ARKG Holding PacBio s 1-Month Returns Top 48%

ARKG holding Pacific Biosciences (PACB) opened lower on Monday, but is still posting one-month returns topping 48%.

United statesMenlo parkPacific biosciencesConsortium for long read sequencing coloSciences corpGinkgo bioworks holdings incIonis pharmaceuticalsCaredx incLong read sequencingTwist biosciencesExact sciences corpXchange traded fundsStock marketArk investIsruptive technology channel

vimarsana © 2020. All Rights Reserved.